Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Depreciation & Amortization (CF): 2022-2025

Historic Depreciation & Amortization (CF) for Gossamer Bio (GOSS) over the last 4 years, with Sep 2025 value amounting to $6,000.

  • Gossamer Bio's Depreciation & Amortization (CF) fell 97.00% to $6,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $126,000, marking a year-over-year decrease of 88.01%. This contributed to the annual value of $833,000 for FY2024, which is 48.16% down from last year.
  • According to the latest figures from Q3 2025, Gossamer Bio's Depreciation & Amortization (CF) is $6,000, which was down 0.00% from $6,000 recorded in Q2 2025.
  • In the past 5 years, Gossamer Bio's Depreciation & Amortization (CF) registered a high of $500,000 during Q1 2022, and its lowest value of $6,000 during Q1 2025.
  • Over the past 3 years, Gossamer Bio's median Depreciation & Amortization (CF) value was $259,000 (recorded in 2024), while the average stood at $234,273.
  • Data for Gossamer Bio's Depreciation & Amortization (CF) shows a maximum YoY slumped of 98.00% (in 2025) over the last 5 years.
  • Gossamer Bio's Depreciation & Amortization (CF) (Quarterly) stood at $432,000 in 2022, then plummeted by 32.41% to $292,000 in 2023, then plummeted by 63.01% to $108,000 in 2024, then slumped by 97.00% to $6,000 in 2025.
  • Its Depreciation & Amortization (CF) stands at $6,000 for Q3 2025, versus $6,000 for Q2 2025 and $6,000 for Q1 2025.